(Q39602064)

English

Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells

scientific article published on 24 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells (English)

1 reference

Europe PubMed Central

13 September 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

Birgit Meller

1

1 reference

Europe PubMed Central

13 September 2017

Margarete Rave-Fränck

2

1 reference

Europe PubMed Central

13 September 2017

Christian Breunig

3

1 reference

Europe PubMed Central

13 September 2017

Markus Schirmer

4

1 reference

Europe PubMed Central

13 September 2017

Manfred Baehre

5

1 reference

Europe PubMed Central

13 September 2017

Roger Nadrowitz

6

1 reference

Europe PubMed Central

13 September 2017

Torsten Liersch

7

1 reference

Europe PubMed Central

13 September 2017

Johannes Meller

8

1 reference

Europe PubMed Central

13 September 2017

publication date

24 January 2011

1 reference

Europe PubMed Central

13 September 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

13 September 2017

187

1 reference

Europe PubMed Central

13 September 2017

2

1 reference

Europe PubMed Central

13 September 2017

120-126

1 reference

Europe PubMed Central

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s00066-010-2191-5

0 references

Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Plasma membrane calcium ATPase (PMCA4): a housekeeper for RT-PCR relative quantification of polytopic membrane proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

PET/CT: will it change the way that we use CT in cancer imaging?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Individualizing treatment for locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Molecular targeted treatment and radiation therapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Increased radioiodine uptake of thyroid cell cultures after external irradiation

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Early effects of irradiation on [(123)I]-IMT and [(18)F]-FDG uptake in rat C6 glioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-010-2191-5

21 January 2018

[The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid rise in FDG uptake in an irradiated human tumour xenograft.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A universal pretargeting system for cancer detection and therapy using bispecific antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of 131-I-CEA antibody as a tumor scanning agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21271227

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-010-2191-5

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39602064&oldid=1844186960"